Cargando…

A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension

Several echocardiographic methods to estimate pulmonary vascular resistance (PVR) have been proposed. So far, most studies have focused on relatively low PVR in patients with a nonspecific type of pulmonary hypertension. We aimed to clarify the clinical usefulness of a new echocardiographic index fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Ya‐Nan, Li, Ai‐Li, Tao, Xin‐Cao, Xie, Wan‐Mu, Gao, Qian, Zhang, Yu, Chen, Ai‐Hong, Lei, Jie‐Ping, Zhai, Zhen‐Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262313/
https://www.ncbi.nlm.nih.gov/pubmed/35833099
http://dx.doi.org/10.1002/pul2.12102
_version_ 1784742467725164544
author Zhai, Ya‐Nan
Li, Ai‐Li
Tao, Xin‐Cao
Xie, Wan‐Mu
Gao, Qian
Zhang, Yu
Chen, Ai‐Hong
Lei, Jie‐Ping
Zhai, Zhen‐Guo
author_facet Zhai, Ya‐Nan
Li, Ai‐Li
Tao, Xin‐Cao
Xie, Wan‐Mu
Gao, Qian
Zhang, Yu
Chen, Ai‐Hong
Lei, Jie‐Ping
Zhai, Zhen‐Guo
author_sort Zhai, Ya‐Nan
collection PubMed
description Several echocardiographic methods to estimate pulmonary vascular resistance (PVR) have been proposed. So far, most studies have focused on relatively low PVR in patients with a nonspecific type of pulmonary hypertension. We aimed to clarify the clinical usefulness of a new echocardiographic index for evaluating markedly elevated PVR in chronic thromboembolic pulmonary hypertension (CTEPH). We studied 127 CTEPH patients. We estimated the systolic and mean pulmonary artery pressure using echocardiography (sPAP(Echo), mPAP(Echo)) and measured the left ventricular internal diameter at end diastole (LVIDd). sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd were then correlated with invasive PVR. Using receiver operating characteristic curve analysis, a cutoff value for the index was generated to identify patients with PVR > 1000 dyn·s·cm(−5). We analyzed pre‐ and postoperative hemodynamics and echocardiographic data in 49 patients who underwent pulmonary endarterectomy (PEA). In this study, mPAP(Echo)/LVIDd moderately correlated with PVR (r = 0.51, p < 0.0001). There was a better correlation between PVR and sPAP(Echo)/LVIDd (r = 0.61, p < 0.0001). sPAP(Echo)/LVIDd ≥ 1.94 had an 77.1% sensitivity and 75.4% specificity to determine PVR > 1000 dyn·s·cm(−5) (area under curve = 0.804, p < 0.0001, 95% confidence interval [CI], 0.66–0.90). DeLong's method showed there was a statistically significant difference between sPAP(Echo)/LVIDd with tricuspid regurgitation velocity(2)/velocity–time integral of the right ventricular outflow tract (difference between areas 0.14, 95% CI, 0.00–0.27). The sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd significantly decreased after PEA (both p < 0.0001). The sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd reduction rate (ΔsPAP(Echo)/LVIDd and ΔmPAP(Echo)/LVIDd) was significantly correlated with PVR reduction rate (ΔPVR), respectively (r = 0.58, p < 0.01; r = 0.69, p < 0.05). In conclusion, the index of sPAP(Echo)/LVIDd could be a simpler and reliable method in estimating CTEPH with markedly elevated PVR and also be a convenient method of estimating PVR both before and after PEA.
format Online
Article
Text
id pubmed-9262313
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92623132022-07-12 A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension Zhai, Ya‐Nan Li, Ai‐Li Tao, Xin‐Cao Xie, Wan‐Mu Gao, Qian Zhang, Yu Chen, Ai‐Hong Lei, Jie‐Ping Zhai, Zhen‐Guo Pulm Circ Research Articles Several echocardiographic methods to estimate pulmonary vascular resistance (PVR) have been proposed. So far, most studies have focused on relatively low PVR in patients with a nonspecific type of pulmonary hypertension. We aimed to clarify the clinical usefulness of a new echocardiographic index for evaluating markedly elevated PVR in chronic thromboembolic pulmonary hypertension (CTEPH). We studied 127 CTEPH patients. We estimated the systolic and mean pulmonary artery pressure using echocardiography (sPAP(Echo), mPAP(Echo)) and measured the left ventricular internal diameter at end diastole (LVIDd). sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd were then correlated with invasive PVR. Using receiver operating characteristic curve analysis, a cutoff value for the index was generated to identify patients with PVR > 1000 dyn·s·cm(−5). We analyzed pre‐ and postoperative hemodynamics and echocardiographic data in 49 patients who underwent pulmonary endarterectomy (PEA). In this study, mPAP(Echo)/LVIDd moderately correlated with PVR (r = 0.51, p < 0.0001). There was a better correlation between PVR and sPAP(Echo)/LVIDd (r = 0.61, p < 0.0001). sPAP(Echo)/LVIDd ≥ 1.94 had an 77.1% sensitivity and 75.4% specificity to determine PVR > 1000 dyn·s·cm(−5) (area under curve = 0.804, p < 0.0001, 95% confidence interval [CI], 0.66–0.90). DeLong's method showed there was a statistically significant difference between sPAP(Echo)/LVIDd with tricuspid regurgitation velocity(2)/velocity–time integral of the right ventricular outflow tract (difference between areas 0.14, 95% CI, 0.00–0.27). The sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd significantly decreased after PEA (both p < 0.0001). The sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd reduction rate (ΔsPAP(Echo)/LVIDd and ΔmPAP(Echo)/LVIDd) was significantly correlated with PVR reduction rate (ΔPVR), respectively (r = 0.58, p < 0.01; r = 0.69, p < 0.05). In conclusion, the index of sPAP(Echo)/LVIDd could be a simpler and reliable method in estimating CTEPH with markedly elevated PVR and also be a convenient method of estimating PVR both before and after PEA. John Wiley and Sons Inc. 2022-07-01 /pmc/articles/PMC9262313/ /pubmed/35833099 http://dx.doi.org/10.1002/pul2.12102 Text en © 2022 The Authors. Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Zhai, Ya‐Nan
Li, Ai‐Li
Tao, Xin‐Cao
Xie, Wan‐Mu
Gao, Qian
Zhang, Yu
Chen, Ai‐Hong
Lei, Jie‐Ping
Zhai, Zhen‐Guo
A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension
title A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension
title_full A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension
title_fullStr A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension
title_full_unstemmed A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension
title_short A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension
title_sort simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262313/
https://www.ncbi.nlm.nih.gov/pubmed/35833099
http://dx.doi.org/10.1002/pul2.12102
work_keys_str_mv AT zhaiyanan asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT liaili asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT taoxincao asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT xiewanmu asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT gaoqian asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT zhangyu asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT chenaihong asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT leijieping asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT zhaizhenguo asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT zhaiyanan simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT liaili simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT taoxincao simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT xiewanmu simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT gaoqian simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT zhangyu simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT chenaihong simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT leijieping simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension
AT zhaizhenguo simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension